A polyglycolated calixarene compound, and a preparation method and application thereof
Nanomicelles constructed by PEGylated calixarane compounds have solved the problems of long treatment cycles and poor water solubility of existing drugs in the treatment of inflammatory diseases. They have enabled precise loading and release of multiple drugs, enhanced anti-inflammatory effects, simplified the synthesis process, and improved biocompatibility and stability.
Patent Information
- Application Number
- CN202510076363.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-01-17
- Publication Date
- 2026-03-20
- Estimated Expiration
- 2045-01-17
AI Technical Summary
Existing drugs for treating inflammatory diseases have problems such as long treatment cycles, poor water solubility, gastrointestinal irritation, and osteoporosis side effects. In addition, the nitric oxide absorption system is relatively simple, making it difficult to achieve effective treatment results.
A polyethylene glycolated calixarene compound was developed, which was used to construct a macrocyclic carrier by linking azo bonds, combined with hydrophilic polyethylene glycol segments to form an amphiphilic molecule, which self-assembled into nanomicelles for regulating nitric oxide absorption under hypoxic conditions, and achieving precise drug release and nitric oxide absorption through the action of azo reductase.
It achieves precise loading and release of multiple drugs, enhances anti-inflammatory effects, simplifies the synthesis process, improves drug biocompatibility and stability, and synergistically treats inflammatory diseases.